Buy PACLITAXEL INJECTION USP 6 MG PACLITAXEL

Paclitaxel Injection USP 6 MG is a chemotherapy medication used to treat various types of cancer. This intravenous solution is manufactured by Sandoz Canada Incorporated and is available in multiple pack sizes.

Strength

6 MG

Pack Size

5ML/16.7ML/25ML/50ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Paclitaxel Injection USP 6 MG is primarily used in cancer treatment. It works by slowing or stopping cancer cell growth. Paclitaxel is often used for breast, lung, and ovarian cancers, among others. Patients and healthcare providers determine the specific uses based on individual medical needs.

Side Effects

Paclitaxel Injection USP 6 MG may cause common side effects such as nausea, vomiting, and hair loss. Some patients may experience fatigue or changes in blood cell counts. Always consult a healthcare provider for personalized information about potential effects.

Precautions & Warnings

Paclitaxel Injection USP 6 MG should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines. Patients should discuss any existing medical conditions or allergies with their healthcare provider before use.

Avoid Interactions

Paclitaxel Injection USP 6 MG may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow your healthcare provider's advice regarding medication use.

References

Frequently Asked Questions

Paclitaxel Injection USP 6 MG is used in the treatment of various types of cancer, including breast, lung, and ovarian cancers.

Paclitaxel Injection USP 6 MG is administered intravenously by a healthcare professional.

Common side effects may include nausea, vomiting, hair loss, and fatigue.

Paclitaxel Injection USP 6 MG may interact with other medications, so it is important to discuss all medications with your healthcare provider.

Precautions include proper handling, storage, and informing your healthcare provider about any existing medical conditions or allergies.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.